Paul Talalay;Albena T. Dinkova-Kostova;Xiangqun Gao
发明人:
Xiangqun Gao,Albena T. Dinkova-Kostova,Paul Talalay
申请号：
US12179986
公开号：
US08303949B2
申请日:
2008.07.25
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention generally relates to the field of treating oxidative stress disorders by administering a pharmaceutically effective amount of a compound that elevates the intracellular levels of glutathone or intracelluar levels of at least one Phase II detoxification enzyme in animal tissue. The present invention also relates to the field of protecting a subject from oxidative stress disorders by administering a pharmaceutically effective amount of a compound that elevates the intracellular levels of glutathone or intracelluar levels of at least one Phase II detoxification enzyme in the subject. The present invention also relates to a pharmaceutical composition useful for the treatment of oxidative stress disorders.
